C Wood

Pregnancy in HIV-infected teenagers in London.

The aim of the study was to describe pregnancies in HIV‐infected teenagers.

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters

We investigated whether adverse responses to highly active antiretroviral therapy (HAART) associated with late HIV presentation are secondary to low CD4 cell count per se or other confounding factors.

Lopinavir and atazanavir in pregnancy: comparable infant outcomes, virological efficacies and preterm delivery rates

The aim of the study was to identify differences in infant outcomes, virological efficacy, and preterm delivery (PTD) outcome between women exposed to lopinavir/ritonavir (LPV/r) and those exposed to atazanavir/ritonavir (ATV/r).

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count

We investigated whether adverse responses to highly active antiretroviral therapy (HAART) associated with late HIV presentation are secondary to low CD4 cell count per se or other confounding factors.

Disseminated candidiasis in two HIV-positive intravenous drug users.

The management of HIV-positive intravenous drug users (IVDU)presents several challenges to health care workers. Although progression of HIV disease in IVDUs appears similar to that in other risk groups, intravenous drug use itself can give rise to symptoms and signs difficult to distinguish from some of those arising as a result of HIV infection. In addition, the clinical course may be punctuated by local and systemic complications of intravenous injection, the management of which, in common with HIV-negative drug users, may be further complicated by poor compliance with medication1. We present 2 patients attending a combined HIVIdrug maintenance clinic who presented with features of disseminated candidiasis, a syndrome which has been recognized increasingly in IVDUs over the last decade.

Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters: Responses to highly active antiretroviral therapy and clinical events

We investigated whether adverse responses to highly active antiretroviral therapy (HAART) associated with late HIV presentation are secondary to low CD4 cell count per se or other confounding factors.